Pfenex soars following agreement to be acquired by Ligand Pharmaceuticals for $12 per share Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Pfenex (PFNX) up 65% after announcing a definitive agreement for Ligand Pharmaceuticals (LGND) to acquire all outstanding shares of the company for $12.00 per share in cash or $438M in equity value on a fully diluted basis
- Equillium (EQ) up 19% after announcing
the first two dose cohorts of itolizumab in the EQUATE study have been generally well tolerated to date and five of seven patients achieved a complete response by Day 29
UP AFTER EARNINGS -
- Lumentum (LITE) up 2%
- Huya (HUYA) up 4%
- NIO Inc. (NIO) up 8%
DOWN AFTER EARNINGS -
- Sysco (SYY) down 3%
- Canada Goose (GOOS) down 4%
- Prevail Therapeutics (PRVL) down 10%
- Itamar Medical (ITMR) down 8%
- BioNTech (BNTX) down 2%
- Tilray (TLRY) down 10%
ALSO LOWER -
- Bed Bath & Beyond (BBBY) down 4% after lifting the suspension of planned debt reductions and commencing cash tender offers to purchase up to $300M aggregate principal amount of its senior notes.
Symbols:
PFNX EQ SYY LITE HUYA NIO GOOS PRVL ITMR BNTX TLRY BBBY Keywords: Fly Intel, Wall Street, Top Stories, Stocks